Pharmaceuticals: Netherlands Industry Guide is an essential resource for top-level data and analysis covering the Netherlands Pharmaceuticals industry. It includes detailed data on market size and segmentation, textual analysis of the key trends and competitive landscape, and profiles of the leading companies. This incisive report provides expert analysis with distinct chapters for Biotechnology, Generics, OTC Pharmaceuticals and Pharmaceuticals.
Scope of the Report
* Contains an executive summary and data on value, volume and segmentation for Biotechnology, Generics, OTC Pharmaceuticals and Pharmaceuticals
* Provides textual analysis of the industry’s prospects, competitive landscape and profiles of the leading companies
* Incorporates in-depth five forces competitive environment analysis and scorecards
* Includes five-year forecasts for Biotechnology, Generics, OTC Pharmaceuticals and Pharmaceuticals
Highlights
* The Dutch biotechnology market grew by 8.2% in 2007 to reach a value of $316 million.
* The Dutch generics market generated total revenues of $771 million in 2007, representing a compound annual growth rate (CAGR) of 32.2% for the period spanning 2003-2007.
* The Dutch OTC pharmaceuticals market generated total revenues of $923.9 million in 2008, representing a compound annual growth rate (CAGR) of 3.3% for the period spanning 2004-2008.
* The Dutch pharmaceutical market generated total revenues of $6.1 billion in 2008, representing a compound annual growth rate (CAGR) of 4.2% for the period spanning 2004-2008.
Why you should buy this report
* Spot future trends and developments
* Inform your business decisions
* Add weight to presentations and marketing materials
* Save time carrying out entry-level research
CHAPTER 1 BIOTECHNOLOGY IN THE NETHERLANDS 10
1.1 Market Overview 10
1.2 Market Value 12
1.3 Market Segmentation I 13
1.4 Market Segmentation II 14
1.5 Five Forces Analysis 15
1.6 Market Forecasts 21
CHAPTER 2 GENERICS IN THE NETHERLANDS 22
2.1 Market Overview 22
2.2 Market Value 24
2.3 Market Segmentation I 25
2.4 Market Segmentation II 26
2.5 Five Forces Analysis 27
2.6 Market Forecasts 34
CHAPTER 3 OTC PHARMACEUTICALS IN THE NETHERLANDS 35
3.1 Market Overview 35
3.2 Market Value 37
3.3 Market Segmentation I 38
3.4 Market Segmentation II 39
3.5 Market Share 40
3.6 Five Forces Analysis 41
3.7 Distribution 47
3.8 Market Forecasts 48
CHAPTER 4 PHARMACEUTICALS IN THE NETHERLANDS 49
4.1 Market Overview 49
4.2 Market Value 51
4.3 Market Segmentation I 52
4.4 Market Segmentation II 53
4.5 Market Share 54
4.6 Five Forces Analysis 55
4.7 Market Forecasts 62
CHAPTER 5 DEMOGRAPHICS 63
CHAPTER 6 APPENDIX 65
6.1 Data Research Methodology 65
LIST OF TABLES
Table 1: Netherlands Biotechnology Market Value: $ million, 2003-2007 12
Table 2: Netherlands Biotechnology Market Segmentation I: % Share, by Value, 2007 13
Table 3: Netherlands Biotechnology Market Segmentation II: % Share, by Value, 2007 14
Table 4: Netherlands Biotechnology Market Value Forecast: $ million, 2007-2012 21
Table 5: Netherlands Generics Market Value: $ billion, 2003-2007 24
Table 6: Netherlands Generics Market Segmentation I: % Share, by Value, 2007 25
Table 7: Netherlands Generics Market Segmentation II: % Share, by Value, 2007 26
Table 8: Netherlands Generics Market Value Forecast: $ billion, 2007-2012 34
Table 9: Netherlands OTC Pharmaceuticals Market Value: $ million, 2004- 2008(e) 37
Table 10: Netherlands OTC Pharmaceuticals Market Segmentation I: % Share, by Value, 2008(e) 38
Table 11: Netherlands OTC Pharmaceuticals Market Segmentation II: % Share, by Value, 2008(e) 39
Table 12: Netherlands OTC Pharmaceuticals Market Share: % Share, by Value, 2007 40
Table 13: Netherlands OTC Pharmaceuticals Distribution: % Share, by Value, 2008(e) 47
Table 14: Netherlands OTC Pharmaceuticals Market Value Forecast: $ million, 2008-2013 48
Table 15: Netherlands Pharmaceuticals Market Value: $ million, 2003-2007 51
Table 16: Netherlands Pharmaceuticals Market Segmentation I: % Share, by Value, 2007 52
Table 17: Netherlands Pharmaceuticals Market Segmentation II: % Share, by Value, 2007 53
Table 18: Netherlands Pharmaceuticals Market Share: % Share, by Value, 2007 54
Table 19: Netherlands Pharmaceuticals Market Value Forecast: $ million, 2007-2012 62
Table 20: Netherlands Size of Population (million) , 2003-2007 63
Table 21: Netherlands GDP (Constant 2000 Prices, $ billion), 2003-2007 63
Table 22: Netherlands Inflation, 2003-2007 63
Table 23: Netherlands Exchange Rate, 2003 64
LIST OF FIGURES
Figure 1: Netherlands Biotechnology Market Value: $ million, 2003-2007 12
Figure 2: Netherlands Biotechnology Market Segmentation I: % Share, by Value, 2007 13
Figure 3: Netherlands Biotechnology Market Segmentation II: % Share, by Value, 2007 14
Figure 4: Forces Driving Competition in the Biotechnology Market in the Netherlands, 2007 15
Figure 5: Drivers of Buyer Power in the Biotechnology Market in the Netherlands, 2007 16
Figure 6: Drivers of Supplier Power in the Biotechnology Market in the Netherlands, 2007 17
Figure 7: Factors Influencing the Likelihood of New Entrants in the Biotechnology Market in the Netherlands, 2007 18
Figure 8: Factors Influencing the Threat of Substitutes in the Biotechnology Market in the Netherlands, 2007 19
Figure 9: Drivers of Degree of Rivalry in the Biotechnology Market in the Netherlands, 2007 20
Figure 10: Netherlands Biotechnology Market Value Forecast: $ million, 2007-2012 21
Figure 11: Netherlands Generics Market Value: $ billion, 2003-2007 24
Figure 12: Netherlands Generics Market Segmentation I: % Share, by Value, 2007 25
Figure 13: Netherlands Generics Market Segmentation II: % Share, by Value, 2007 26
Figure 14: Forces Driving Competition in the Generics Market in the Netherlands, 2007 27
Figure 15: Drivers of Buyer Power in the Generics Market in the Netherlands, 2007 29
Figure 16: Drivers of Supplier Power in the Generics Market in the Netherlands, 2007 30
Figure 17: Factors Influencing the Likelihood of New Entrants in the Generics Market in the Netherlands, 2007 31
Figure 18: Factors Influencing the Threat of Substitutes in the Generics Market in the Netherlands, 2007 32
Figure 19: Drivers of Degree of Rivalry in the Generics Market in the Netherlands, 2007 33
Figure 20: Netherlands Generics Market Value Forecast: $ billion, 2007-2012 34
Figure 21: Netherlands OTC Pharmaceuticals Market Value: $ million, 2004-2 2008(e) 37
Figure 22: Netherlands OTC Pharmaceuticals Market Segmentation I: % Share, by Value, 2008(e) 38
Figure 23: Netherlands OTC Pharmaceuticals Market Segmentation II: % Share, by Value, 2008(e) 39
Figure 24: Netherlands OTC Pharmaceuticals Market Share: % Share, by Value, 2007 40
Figure 25: Forces Driving Competition in the OTC Pharmaceuticals Market in the Netherlands 41
Figure 26: Drivers of Buyer Power in the OTC Pharmaceuticals Market in the Netherlands 42
Figure 27: Drivers of Supplier Power in the OTC Pharmaceuticals Market in the Netherlands 43
Figure 28: Factors Influencing the Likelihood of New Entrants in the OTC Pharmaceuticals Market in the Netherlands 44
Figure 29: Factors Influencing the Threat of Substitutes in the OTC Pharmaceuticals Market in the Netherlands 45
Figure 30: Drivers of Degree of Rivalry in the OTC Pharmaceuticals Market in the Netherlands 46
Figure 31: Netherlands OTC Pharmaceuticals Distribution: % Share, by Value, 2008(e) 47
Figure 32: Netherlands OTC Pharmaceuticals Market Value Forecast: $ million, 2008-2013 48
Figure 33: Netherlands Pharmaceuticals Market Value: $ million, 2003-2007 51
Figure 34: Netherlands Pharmaceuticals Market Segmentation I: % Share, by Value, 2007 52
Figure 35: Netherlands Pharmaceuticals Market Segmentation II: % Share, by Value, 2007 53
Figure 36: Netherlands Pharmaceuticals Market Share: % Share, by Value, 2007 54
Figure 37: Forces Driving Competition in the Pharmaceuticals Market in the Netherlands, 2007 55
Figure 38: Drivers of Buyer Power in the Pharmaceuticals Market in the Netherlands, 2007 56
Figure 39: Drivers of Supplier Power in the Pharmaceuticals Market in the Netherlands, 2007 57
Figure 40: Factors Influencing the Likelihood of New Entrants in the Pharmaceuticals Market in the Netherlands, 2007 59
Figure 41: Factors Influencing the Threat of Substitutes in the Pharmaceuticals Market in the Netherlands, 2007 60
Figure 42: Drivers of Degree of Rivalry in the Pharmaceuticals Market in the Netherlands, 2007 61
Figure 43: Netherlands Pharmaceuticals Market Value Forecast: $ million, 2007-2012 62
Other selected research from the 'Netherlands' category:
Pharmaceuticals: Netherlands Industry Guide
Pharmaceuticals: Netherlands Industry Guide
Other selected research from the 'Markets' category:
Pharmaceuticals in the Netherlands
Lipitor Market analysis and forecasts Report, 2007-2012, 2017 & 2023